Fluent

Fluent EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Fluent (TIUM.U.CN) as of Nov 5, 2026 is 13.42 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 7.02 % — a change of 91.27% (higher).

EBIT/Assets

13.42 %

YoY

91.27%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Fluent is 2023 13.42 % . Operating Income to Assets Ratio (EBIT/Assets) of Fluent was 2022 7.02 % . It decreases by 91.27% higher compared to the previous year.

The Fluent EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
-24.30 USD
Jan 1, 2020
-16.78 USD
Jan 1, 2021
-8.49 USD
Jan 1, 2022
7.02 USD
Jan 1, 2023
13.42 USD
The Fluent EBIT/Assets history
YEAREBIT/AssetsYoY
13.42 %+91.27%
7.02 %-182.64%
-8.49 %-49.39%
-16.78 %-30.94%
-24.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Operating Income to Assets Ratio (EBIT/Assets) of Fluent is 13.42 % in 2023.

Operating Income to Assets Ratio (EBIT/Assets) of Fluent changed from 7.02 % to 13.42 %, representing a 91.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Fluent since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Fluent with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Fluent

All Key Metrics — Fluent